Table 3

Arrhythmia and Mode of Death

Placebo (No Arrhythmia n = 867, Arrhythmia, n = 117)Carvedilol (No Arrhythmia, n = 924, Arrhythmia, n = 51)
Death from any cause*
 No arrhythmia116 (13.4%)103 (11.1%)
 Arrhythmia35 (29.9%)13 (25.5%)
Sudden death
 No arrhythmia (n = 924)53 (6.1%)46 (5.0%)
 Arrhythmia (n = 51)16 (13.7%)5 (9.8%)
  • * 14 subjects in the placebo group died within 2 days of the arrhythmia report compared with 1 in the carvedilol group;

  • 8 subjects in the placebo group experienced sudden death within 2 days of the arrhythmia report compared with 0 in the carvedilol group.